New filler aims to smooth deep wrinkles
NCT ID NCT07467239
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new injectable called DMFI300 for treating nasolabial folds (the lines from nose to mouth corners). Thirty adults will receive DMFI300 on one side of the face and a comparator filler on the other. Researchers will check wrinkle severity and safety over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- polycaprolactone 300 (DMFI300)
- What this could lead to
- If it works, this could offer a new option for reducing deep smile lines with effects lasting up to a year.
- What could go wrong
- This is a small, early-stage trial with only 30 people, so results may not apply to everyone. As with any injectable, risks include swelling, bruising, or uneven results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOLABIAL FOLDS, WRINKLES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ocean Clinic
RECRUITINGMarbella, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.